|
|
|
The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders
Over the past half-century, the social terrain of health and illness has been transformed What were once considered normal human events and common human problems -- birth, aging, menopause, alcoholism, and obesity -- are now viewed as medical conditions. For better or worse, medicine increasingly permeates aspects of daily life. Building on more than three decades of research, Peter Conrad explores the changing forces behind this trend with case studies of short stature, social anxiety, "male menopause," erectile dysfunction, adult ADHD, and sexual orientation. He examines the emergence of and changes in medicalization, the consequences of the expanding medical domain, and the implications for health and society. He finds in recent developments -- such as the growing number of possible diagnoses and biomedical enhancements -- the future direction of medicalization. Conrad contends that the impact of medical professionals on medicalization has diminished. Instead, the pharmaceutical and biotechnical industries, insurance companies and HMOs, and the patient as consumer have become the major forces promoting medicalization. This thought-provoking study offers valuable insight into not only how medicalization got to this point but also how it may continue to evolve. .
Price: $11.99
[ Notify me when price goes down.]
|
|
Personality-Disordered Patients: Treatable and Untreatable
Determining the amenability of personality disorders to psychotherapy -- a patient's capacity to benefit from verbal approaches to treatment -- is important in helping clinicians determine the treatability of cases. Michael Stone here shares the factors he has observed over long years of practice that can help practitioners evaluate patients, stressing the amenability of the various disorders to amelioration. By focusing on which patients are likely to respond well to therapeutic intervention and which will prove most resistive, his book will help therapists determine with what kinds of patients they will most likely succeed and with which ones failure is almost a certainty. Stone establishes the attributes that affect this amenability -- such as the capacity for self-reflection, motivation, and life circumstances's guidelines for evaluating patients, then describes borderline and other personality-disordered patients with varying levels of amenability, from high to low. This coverage progresses from patients belonging to the DSM "anxious cluster," along with the depressive-masochistic character and the hysteric character, to patients who demonstrate an intermediate level of amenability to psychotherapy. He introduces the interrelationship between borderline personality disorder and dissociative disorders and discusses treatability among certain patients in Clusters "A" and "C," as well as others with narcissistic, histrionic, depressive disorders. Final chapters address the most severe aberrations of personality and the limitations they impose on the efficacy of therapy. Personality-Disordered Patients is filled with practical, clinically focused information. This guideline structured book: - Covers all personality disorders-including ones not addressed in the latest DSM such as sadistic, depressive, hypomanic, and irritable-explosive
- Identifies both attributes necessary for treatability and factors associated with low treatability
- Pays particular attention to borderline disorders, which represent the most discussed conditions and are among the most challenging to psychotherapists
- Reviews personality traits whose presence, if intense-even if unaccompanied by a definable personality disorder-creates severe problems for psychotherapy
Numerous case studies throughout the book provide examples that will help therapists determine which of their own patients are most likely to benefit from their efforts and thereby establish their own limits of effectiveness. By alerting practitioners to when therapy is likely to fail, these guidelines can help them avoid the professional disappointment of being unable to reach the most intractable patients..
Price: $44.45
[ Notify me when price goes down.]
|
|
Expert offers encopresis treatment pearls: clinician says this form of fecal incontinence is highly treatable, but can take 6 months to a year.(Clinical Rounds): An article from: Pediatric News
This digital document is an article from Pediatric News, published by Thomson Gale on November 1, 2005. The length of the article is 1015 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation DetailsTitle: Expert offers encopresis treatment pearls: clinician says this form of fecal incontinence is highly treatable, but can take 6 months to a year.(Clinical Rounds) Author: Robert Finn Publication:Pediatric News (Magazine/Journal) Date: November 1, 2005 Publisher: Thomson Gale Volume: 39 Issue: 11 Page: 43(1) Distributed by Thomson Gale.
Price: $5.95
[ Notify me when price goes down.]
|
|
The 2006-2011 World Outlook for Flat, Non-Heat-Treatable, Bare and Precoated Aluminum and Continuous Cast Sheet and Strip
WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The âmarketâ is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for flat, non-heat-treatable, bare and precoated aluminum and continuous cast sheet and strip is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either lower or higher than actual sales if a market is inefficient (i.e., not representative of relatively competitive levels). Inefficiencies arise from a number of factors, including the lack of international openness, cultural barriers to consumption, regulations, and cartel-like behavior on the part of firms. In general, however, latent demand is typically larger than actual sales in a country market. For reasons discussed later, this report does not consider the notion of âunit quantitiesâ, only total latent revenues (i.e., a calculation of price times quantity is never made, though on.
Price: $795.00
[ Notify me when price goes down.]
|
|
The 2007-2012 World Outlook for Coiled, Heat-Treatable Aluminum Sheet and Strip
This study covers the world outlook for coiled, heat-treatable aluminum sheet and strip across more than 200 countries For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved..
Price: $795.00
[ Notify me when price goes down.]
|
|
Menstrual migraines: more severe but treatable.(Women's Health): An article from: Family Practice News
This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 2004. The length of the article is 612 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation DetailsTitle: Menstrual migraines: more severe but treatable.(Women's Health) Author: Diana Mahoney Publication:Family Practice News (Magazine/Journal) Date: August 15, 2004 Publisher: International Medical News Group Volume: 34 Issue: 16 Page: 36(1) Distributed by Thomson Gale.
Price: $5.95
[ Notify me when price goes down.]
|
|
The 2007-2012 World Outlook for Coiled, Non-Heat-Treatable, Bare Aluminum Sheet and Strip
This study covers the world outlook for coiled, non-heat-treatable, bare aluminum sheet and strip across more than 200 countries For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved..
Price: $795.00
[ Notify me when price goes down.]
|
|
|
|
|